Sign In
Buy GILD
$125.16
+0.110 (+0.0880%)
At Close: Jun 24, 2026
Biotech Sector Nears Breakout: Will it Outperform in Q2?
06:11am, Wednesday, 03'rd Apr 2024
The popular iShares Biotechnology ETF NASDAQ: IBB has formed a bullish consolidation in the upper portion of its 52-week range, hinting at a significant sector-wide breakout.
My April Dividend Stock Buys With Yields Up To 12%
02:17am, Tuesday, 02'nd Apr 2024
My April Dividend Stock Buys With Yields Up To 12%
7 Value Stocks to Buy at a 52-Week Low in March
06:45am, Thursday, 28'th Mar 2024
When it comes to finding the best value stocks to buy, sometimes you have to go against the grain. That is, dive into stocks that have fallen out of favor with the market, to assess whether investor s
Gilead Sciences Finally Starts Succeeding
04:43am, Thursday, 21'st Mar 2024
Gilead Sciences has a strong track record in curing Hepatitis C and a successful HIV business. The company has struggled with acquisitions but is expected to generate strong shareholder returns. Gilea
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
10:05am, Wednesday, 20'th Mar 2024
Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Gilead Sciences (GILD) Rises But Trails Market: What Investors Should Know
07:05pm, Tuesday, 19'th Mar 2024
Gilead Sciences (GILD) reachead $73.41 at the closing of the latest trading day, reflecting a +0.2% change compared to its last close.
2 Top Dividend Stocks to Buy Hand Over Fist
08:15am, Sunday, 17'th Mar 2024
AbbVie and Gilead Sciences haven't been recording excellent financial results lately. But both drugmakers have solid lineups and pipelines that should allow them to recover.
Gilead CAR-T cancer therapy capacity to quadruple by 2026
06:04am, Friday, 15'th Mar 2024
Gilead Sciences will be able to quadruple production of its cell therapy cancer treatments by 2026 due to improvements in the U.S. biotech's manufacturing processes, an executive in charge of that bus
Gilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know
07:06pm, Wednesday, 13'th Mar 2024
Gilead Sciences (GILD) closed the most recent trading day at $75.94, moving +1.15% from the previous trading session.
Gilead Sciences, Inc. (GILD) Leerink Partners Global Biopharma Conference (Transcript)
08:26pm, Tuesday, 12'th Mar 2024
Gilead Sciences, Inc. (GILD) Leerink Partners Global Biopharma Conference (Transcript)
39 Upcoming Dividend Increases Including 2 Dividend Kings
11:48am, Friday, 08'th Mar 2024
Thirty-nine companies, including Coca-Cola and Telephone and Data Systems, are raising their dividends.
Why Gilead Sciences (GILD) Outpaced the Stock Market Today
06:55pm, Thursday, 07'th Mar 2024
In the most recent trading session, Gilead Sciences (GILD) closed at $73.66, indicating a +1.42% shift from the previous trading day.
Gilead (GILD) & MRK's HIV Oral Combo Shows Efficacy in Phase II
09:00am, Thursday, 07'th Mar 2024
Gilead (GILD) and Merck's (MRK) phase II study data demonstrates the efficacy of their oral once-weekly combination of islatravir and lenacapavir in maintaining viral suppression in individuals with H
Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock
10:00am, Wednesday, 06'th Mar 2024
Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Gilead Sciences, Inc. (GILD) Presents at TD Cowen 44th Annual Health Care Conference (Transcript)
03:39pm, Tuesday, 05'th Mar 2024
Gilead Sciences, Inc. (NASDAQ:GILD ) TD Cowen 44th Annual Health Care Conference March 5, 2024 12:50 PM ET Company Participants Andy Dickinson - Chief Financial Officer Conference Call Participants Ty
